Form 8-K - Current report:
SEC Accession No. 0001104659-25-080998
Filing Date
2025-08-21
Accepted
2025-08-20 18:20:11
Documents
13
Period of Report
2025-08-18
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2523917d1_8k.htm   iXBRL 8-K 60928
2 EXHIBIT 3.1 tm2523917d1_ex3-1.htm EX-3.1 7187
  Complete submission text file 0001104659-25-080998.txt   238782

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hypd-20250818.xsd EX-101.SCH 3026
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hypd-20250818_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hypd-20250818_pre.xml EX-101.PRE 22366
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2523917d1_8k_htm.xml XML 3690
Mailing Address 23461 SOUTH POINTE DRIVE, SUITE 390 LAGUNA HILLS CA 92653
Business Address 23461 SOUTH POINTE DRIVE, SUITE 390 LAGUNA HILLS CA 92653 833-393-6684
HYPERION DEFI, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 251238001
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)